[1]DOIG KD,FELLOWES AP,FOX SB.Homologous recombination repair deficiency:An overview for pathologists[J].Modern Pathology,2023,36(3):100049.
[2] COLLINS A,MOLLER P,GAJSKI G,et al.Measuring DNA modifications with the comet assay:a compendium of protocols[J].Nature Protocols,2023,18(3):929-989.
[3] BARSZCZEWSKA PG,DRZEWIECKA M,CZARNY P,et al.Polθ inhibition:An anticancer therapy for HR-deficient tumours[J].International Journal of Molecular Sciences,2022,24(1):319.
[4] CHRISTIE SM,FIJEN C,ROTHENBERG E.V(D)J recombination:Recent insights in formation of the recombinase complex and recruitment of DNA repair machinery[J].Frontiers in Cell and Developmental Biology,2022,10:886718.
[5] DE GROOTD,SPANJAARD A,HOGENBIRK MA,et al.Chromosomal rearrangements and chromothripsis:The alternative end generation model[J].International Journal of Molecular Sciences,2023,24(1):794.
[6] HUANG J,COOK DE.The contribution of DNA repair pathways to genome editing and evolution in filamentous pathogens[J].FEMS Microbiology Reviews,2022,46(6):fuac035.
[7] SHI X,ZHAO S,CHEN S,et al.Tetramethylpyrazine in Chinese baijiu:Presence,analysis,formation,and regulation[J].Frontiers in Nutrition,2022,9:1004435.
[8] IANG R,XU J,ZHANG Y,et al.Ligustrazine alleviate acute lung injury through suppressing pyroptosis and apoptosis of alveolar macrophages[J].Front Pharmacol,2021,12:680512.
[9] LI X,LIN Z,WANG P,et al.Tetramethylpyrazine-rhein derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation[J].Biomed Pharmacother,2023,162:114731.
[10] LIN J,WANG Q,ZHOU S,et al.Tetramethylpyrazine:A review on its mechanisms and functions[J].Biomed Pharmacother,2022,150:113005.
[11] ZHENG H,WANG S,ZHOU P,et al.Effects of Ligustrazine on DNA damage and apoptosis induced by irradiation[J].Environmental Toxicology and Pharmacology,2013,36(3):1197-11206.
[12] TODOROVA T,MITEVA D,CHANKOVA S.DNA susceptibility of Saccharomyces cerevisiae to Zeocin depends on the growth phase[J].International Microbiology,2019,22(4):419-4428.
[13] GUNN A,STARK JM.I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks[J].Methods in Molecular Biology,2012,920:379-391.
[14] ZHANG FL,YANG SY,LIAO L,et al.Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer[J].Theranostics,2023,13(3):973-990.
[15] LORD CJ,ASHWORTH A.The DNA damage response and cancer therapy[J].Nature,2012,481(7381):287-294.
[16] YU Y,YU J,GE S,et al.Novel insight into metabolic reprogrammming in cancer radioresistance:A promising therapeutic target in radiotherapy[J].International Journal of Biological Sciences,2023,19(3):811-828.
[17] LIPTAY M,BARBOSA JS,ROTTENBERG S.Replication fork remodeling and therapy escape in DNA damage response-deficient cancers[J].Frontiers in Oncology,2020,10:670.
[18] LUO J,LI Y,ZHANG T,et al.Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications[J].Frontiers in Oncology,2022,12:1092705.
[19] JACKSON SP,BARTEK J.The DNA-damage response in human biology and disease[J].Nature,2009,461(7267):1071-1078.
[20] XU Y,XU D.Repair pathway choice for double-strand breaks[J].Essays in Biochemistry,2020,64(5):765-777.
[21] HER J,BUNTING SF.How cells ensure correct repair of DNA double-strand breaks[J].The Journal of Biological Chemistry,2018,293(27):10502-10511.